- Design Patents Practice
- Due Diligence in IP Acquisitions
- Life Sciences Practice Group
- Patent Landscaping and Risk Analysis
- Pharmaceutical Practice Group
- Strategic IP Portfolio Development and Management
- Chemical Engineering
- Environmental Engineering
- Food Science
- Metallurgy & Ceramics
- Pharmaceuticals & Pharmaceutical Formulation
- Polymer & Materials Science
- U.S. Patent and Trademark Office, 2003
- Connecticut, 2005
Quinnipiac University School of Law, J.D., 2005
Case Western Reserve University School of Medicine, Ph.D. in Cell Physiology and Biophysics, 2000
Miami University, B.A. in Zoology, 1993
Bryan D. Zerhusen, Ph.D.
Bryan Zerhusen's practice spans all aspects of domestic and foreign patent preparation, prosecution, and counseling for innovators in the chemical and life science industries. Chair of the firm's Life Sciences Practice Group, Bryan’s clients include solo inventors, academic institutions, foreign law firms, venture firms, as well as companies ranging from start-ups to global corporations in the medical biotechnology, agricultural biotechnology, diagnostic, chemical, pharmaceutical, medical device and healthcare sectors.
In particular, Bryan routinely performs patent drafting and prosecution; counsels clients on strategic IP portfolio management; prepares patentability and freedom-to-operate searching, analysis and opinions; prosecutes patent reexaminations; conducts due diligence investigations; and provides IP litigation support. Bryan also has extensive experience negotiating and preparing agreements relevant to the life science industry, including collaborative agreements and IP licensing agreements on behalf of solo inventors, venture firms, start-ups and emerging companies.
Partner and Chair, Life Sciences Practice Group, Cantor Colburn LLP, 2018-present
Partner and Co-Chair, Life Sciences Practice Group, Locke Lord LLP, 2014-2018
Partner, McCarter & English, LLP, 2012-2014
Patent Attorney, McCarter & English, LLP, 2003-2012
Research Scientist, CuraGen Corporation, 2000-2003
- Procured domestic and international patent protection for a biopharmaceutical start-up company from inception through three fund raising rounds, multiple industry collaborations, public offering, and anticipated first IND filing.
- Performed a large-scale due diligence study of an innovative biotechnology company developing novel antibody-based therapeutics for a global venture firm in connection with a $40 MM investment round.
- Performed a large-scale due diligence study for a consortium of venture firms in connection with a $15 MM investment in a company developing novel strategies for developing small molecules that target proteins for degradation.
- Procured domestic and international patent protection for a biotechnology start-up company for an IND-ready protein therapeutic.
- Petitioned and prosecuted the Inter partes reexamination of three patents covering dietary supplement formulations for a client wishing to make and sell related products.
- Defended ex parte and inter partes reexaminations on behalf of a large pharmaceutical company for a drug formulation generating $100 MM/year in revenue.
- July 16, 2018
Intellectual Property Owners Association (IPO)
American Intellectual Property Law Association (AIPLA)
Association of University Technology Managers (AUTM)
Boston Patent Law Association